Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
Similar to other cancers, myeloid malignancies are thought to subvert the immune system during their development. This subversion occurs via both malignant cell-autonomous and non-autonomous mechanisms and involves manipulation of the innate and adaptive immune systems. Multiple strategies are being...
Guardado en:
Autores principales: | Sara Small, Yazan Numan, Leonidas C. Platanias |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae3df64a813045f1920fbc5ebf226af4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Conventional Cytogenetic and Molecular Analysis in Acute Myeloid Leukemia (AML) and Their Association with Overall Survival
por: Shakeri S., et al.
Publicado: (2021) -
The clinical heterogeneity of RUNX1 associated familial platelet disorder with predisposition to myeloid malignancy – A case series and review of the literature
por: Catherine Tang, et al.
Publicado: (2020) -
Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
por: Patrick Schreiner, et al.
Publicado: (2021) -
Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Alessandro Allegra, et al.
Publicado: (2021) -
Subdural intracranial myeloid sarcoma without myelogenous disorder: Case report
por: Shahed Elhamdani, et al.
Publicado: (2022)